JOSEPH JANKOVIC to United States Food and Drug Administration
This is a "connection" page, showing publications JOSEPH JANKOVIC has written about United States Food and Drug Administration.
Connection Strength
0.141
-
Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors. Drugs. 2018 04; 78(5):525-541.
Score: 0.141
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.